Robinson Rebekah L, Sharma Ashok, Bai Shan, Heneidi Saleh, Lee Tae Jin, Kodeboyina Sai Karthik, Patel Nikhil, Sharma Shruti
Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.
Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA, United States.
Front Oncol. 2019 Feb 26;9:72. doi: 10.3389/fonc.2019.00072. eCollection 2019.
Renal cell carcinomas (RCC) are heterogeneous and can be further classified into three major subtypes including clear cell, papillary and chromophobe. Signal transducer and activator of transcription 3 (STAT3) is commonly hyperactive in many cancers and is associated with cancer cell proliferation, invasion, migration, and angiogenesis. In renal cell carcinoma, increased STAT3 activation is associated with increased metastasis and worse survival outcomes, but clinical trials targeting the STAT3 signaling pathway have shown varying levels of success in different RCC subtypes. Using RNA-seq data from The Cancer Genome Atlas (TCGA), we compared expression of 32 STAT3 regulated genes in 3 RCC subtypes. Our results indicate that STAT3 activation plays the most significant role in clear cell RCC relative to the other subtypes, as half of the evaluated genes were upregulated in this subtype. were upregulated and was downregulated in all three subtypes. Several genes including , and had variable expression in RCC subtypes and are potential therapeutic targets for personalized medicine.
肾细胞癌(RCC)具有异质性,可进一步分为三种主要亚型,包括透明细胞型、乳头状型和嫌色细胞型。信号转导和转录激活因子3(STAT3)在许多癌症中通常过度活跃,与癌细胞的增殖、侵袭、迁移和血管生成有关。在肾细胞癌中,STAT3激活增加与转移增加和较差的生存结果相关,但针对STAT3信号通路的临床试验在不同的RCC亚型中显示出不同程度的成功。利用来自癌症基因组图谱(TCGA)的RNA测序数据,我们比较了32个STAT3调控基因在3种RCC亚型中的表达。我们的结果表明,相对于其他亚型,STAT3激活在透明细胞RCC中起最显著作用,因为在该亚型中一半的评估基因上调。在所有三种亚型中,有 个基因上调, 个基因下调。包括 、 和 在内的几个基因在RCC亚型中表达可变,是个性化医学的潜在治疗靶点。